New York Life Investment Management’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-26,362
Closed -$471K 1341
2023
Q4
$471K Sell
26,362
-774
-3% -$12K ﹤0.01% 872
2023
Q3
$411K Sell
27,136
-4,325
-14% -$70K ﹤0.01% 849
2023
Q2
$541K Sell
31,461
-6,668
-17% -$98.2K 0.01% 676
2023
Q1
$499K Buy
+38,129
New +$487K 0.01% 676

Other funds holding AORT

New York Life Investment Management's AORT Position: Q1 2024 in Review

New York Life Investment Management sold out of Artivion (AORT) in Q1 2024, closing a stake of 26,362 shares — an estimated $471K sold.

New York Life Investment Management first reported a position in AORT in Q1 2023 and held it in 4 quarters. The position peaked at $541K in Q2 2023. 151 funds tracked by Wall St. Rank hold AORT as of Q1 2024.

  • New York Life Investment Management reported no remaining Artivion position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 26,362 Artivion shares in Q1 2024, an estimated $471K.
  • New York Life Investment Management first reported a position in Artivion in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's Artivion position peaked at $541K in Q2 2023.
  • 151 funds tracked by Wall St. Rank held Artivion as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.